THURSDAY, NOVEMBER 23, 2017

Smartphones shown to boost disease surveillance capabilities

The development of smartphone technology has the potential to boost the disease surveillance capability of developing countries. Read More »

Japan donates $340 million to the Global Fund

Japan recently donated $340 million to The Japan recently donated $340 million to The Global Fund to Fight AIDS, Tuberculosis and Malaria. Read More »

Gates Foundation provides grant for TB biomarkers program

The Foundation of UMDNJ, an affiliate of the New Jersey Health Foundation, announced on Wednesday that it has received a tuberculosis biomarkers grant through the Bill and Melinda Gates Foundation. Read More »

Dengue fever cases double in Peru

Public health authorities in the Cajamarca region of northern Peru are reporting double the number of dengue fever cases confirmed this year in comparison to the same period in 2011. Read More »

Newly polio-free India reports suspected case of polio

Just two weeks after the World Health Organization declared India a polio-free nation, an 18-month-old child was admitted to a Kolkata hospital with a suspected case of the crippling disease. Read More »

Oxford-Emergent Tuberculosis Consortium's Adam Stoten discusses goal of new TB vaccines

In an interview with Human Vaccines, Adam Stoten, the deputy general manager of the Oxford-Emergent Tuberculosis Consortium, discussed the OETC's mission to create new, efficacious tuberculosis vaccines based on MVA85A. Read More »

MediVector awarded DoD contract for broad-spectrum influenza therapeutic

The Department of Defense's Joint Project Manager Transformational Medical Technologies announced on Thursday that it has awarded a $138.5 million contract to MediVector, Inc., for the further development of a broad-spectrum influenza therapeutic. Read More »

Gates Foundation commits up to $220 million to Aeras for new TB vaccines

The Bill and Melinda Gates Foundation has committed as much as $220 million over the next five years to Aeras, a Rockville, Maryland-based non-profit dedicated to developing new tuberculosis vaccines. Read More »

Simulations Plus announces success of molecule that inhibits malaria

Simulations Plus, Inc., recently announced that a molecule it created to inhibit the malaria parasite has performed successfully in preliminary testing. Read More »

Influenza mechanism that interferes with antiviral host responses found

Researchers from The Rockefeller University recently identified a novel mechanism used by the influenza virus to interfere with antiviral host responses. Read More »

Greece's health budget cuts have led to increase in malaria, HIV/AIDS

According to Doctors Without Borders, major cuts to the health budget in Greece have led to an increase in malaria and HIV/AIDS among some groups. Read More »

Flu cases drop by 97 percent in Pennsylvania

Cases of the flu have declined by 97 percent in Pennsylvania this year, possibly because of the combination between a mild winter, higher vaccination rates and people taking more precautions to avoid flu spread. Read More »

Pakistan reporting dengue fever cases earlier than normal

Even without monsoon rains and high temperatures, public health experts have already started registering cases of dengue fever this year in Karachi, Pakistan. Read More »

FDA proposes rule to spur development of TB tests

The U.S. Food and Drug Administration recently proposed a rule intended to spur the development of a type of tuberculosis test. Read More »

World TB Day: Tuberculosis Alliance announces final clinical trials for new drug regimen

The Tuberculosis Alliance announced the final clinical trials of a promising new drug regimen for the treatment of drug-resistant tuberculosis on Monday. Read More »

World TB Day: NIAID expands tuberculosis clinical trial capacity

In order to streamline tuberculosis drug research, the National Institute of Allergy and Infectious Diseases has begun using established HIV/AIDS networks to conduct clinical TB drug research. Read More »

International Roadmap for TB outlines challenges in TB fight

In the recently published International Roadmap for TB, three TB experts recently discussed the progress that has been made in TB vaccine research and the challenges that remain in fully realizing a blueprint for vaccine research and development. Read More »

CDC warns of measles at London Olympics

The U.S. Centers for Disease Control and Prevention has warned that the London Olympics and the Euro 2012 soccer cup will be major draws for American travelers, leading to an increased risk of measles infection. Read More »

Mosquito Squad partners with Malaria No More

Mosquito Squad, a mosquito and tick control company based in the United States, recently announced that it is partnering with Malaria No More to help eliminate the mosquito-borne illness in Africa. Read More »

PaxVax announces progress on single-dose oral cholera vaccine

PaxVax Corporation, a developer of oral vaccines, recently announced that the U.S. Food and Drug Administration has accepted its investigational new drug application for a single-dose oral vaccine targeting cholera. Read More »